Stomach neuroendocrine cancer

Stomach (gastric) neuroendocrine cancer develop in neuroendocrine cells Open a glossary item in the stomach. You might also hear them called stomach neuroendocrine neoplasms (NENs).

There are 2 key groups of stomach neuroendocrine cancer: 

  • stomach neuroendocrine tumours (NETs) - there are 3 types (type 1, 2 and 3)
  • stomach neuroendocrine carcinomas (NECs) - the 2 main types are large cell and small cell

NETs and NECs are very different. So it is important to know which one you have. Talk to your doctor or specialist nurse if you are not sure.

What are stomach neuroendocrine cancers?

Stomach neuroendocrine cancers are rare. You might not have symptoms. If you do, these might include tummy pain, feeling or being sick or unexplained weight loss.

Grades, types and stages of stomach neuroendocrine cancer

There are 3 types of stomach neuroendocrine tumours (NET) - type 1, type 2 and type 3. There are 2 types of stomach neuroendocrine carcinomas (NEC) - small cell and large cell. 

Treatment by type of stomach NET

The treatment you have for a stomach neuroendocrine tumour (NET) depends on a number of things. This includes the type of NET and whether it has spread.

Treatment for stomach NETs that have spread

There are a number of different treatment options if you have a stomach NET that has spread. The best treatment for you depends on where in your body the NET has spread to.

Follow up for stomach NETs

You have regular appointments with your doctor or nurse after treatment for your stomach NET finishes. This is called follow up.

Research into stomach NETs

Researchers are looking at the biology of neuroendocrine tumours. And are trying to improve the diagnosis and treatment of stomach NETs.

Survival

Survival depends on many different factors. It depends on your type of neuroendocrine tumour, treatment and level of fitness. Find out about survival for the different types of stomach NETs.

Living with NETs

Get practical and emotional support to help you cope with a neuroendocrine tumour.

Last reviewed: 
11 Feb 2025
Next review due: 
11 Feb 2028